BRIEF

on Biotricity, Inc. (NASDAQ:BTCY)

Biotricity Partners with Health Aid Africa for Heart Health Screenings at Charity Concert

Biotricity Inc., a leader in Technology-as-a-Service for the medical and healthcare sectors, has announced a strategic partnership with Health Aid Africa. This collaboration is set to enhance the upcoming charity concert at Allegiant Stadium by offering complimentary heart health screenings to attendees. This initiative aligns with Biotricity's mission to revolutionize medical diagnostics and consumer healthcare.

The Health Aid Africa charity concert, featuring a lineup of diverse musical acts, aims to raise awareness and funds for health technology in underserved regions. The event also serves as a global platform, with live streaming ensuring a worldwide reach. It highlights the integration of healthcare, technology, and philanthropy, spearheaded by notable leaders such as Eddie Tantoco, Elora Tran, Dustin Salinas, and Andre Roberson.

Additionally, the concert will benefit from contributions by Dr. Jere Rivera-Dugenio of Rasha LTD Inc., via the donation of a Rasha dome for performer preparation and utilization of the JustGoingViral platform for wider event promotion. Silicon Valley HQ has volunteered to provide upskilling opportunities, including webinars and mentorship, to empower African students and entrepreneurs further.

The collaboration is not only a testament to Biotricity's commitment to healthcare innovation but also offers an unparalleled opportunity for brand exposure and engagement in a mix of music, wellness, and philanthropy. The event underscores the importance of combining entertainment with significant health initiatives and global outreach.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Biotricity, Inc. news